MPN Patient Symposium Videos

Every other year, CR&T hosts the International Patient Symposium on Myeloproliferative Neoplasms (MPNs).  This full-day educational event takes place in New York City, and is an opportunity for patients and caregivers to learn about the latest developments in MPN research and treatment.  Each year, the program features presentations by distinguished basic scientists and clinical research physicians from the world’s leading MPN centers.

If you weren’t able to attend previous symposia, or if you attended and would like to view the talks again, you can watch these presentations at your convenience.

10th International Patient Symposium on Myeloproliferative Neoplasms

CR&T was proud to host the 10th International Patient Symposium on Myeloproliferative Neoplasms on Wednesday, October 23, 2019, at Weill Cornell Medicine in New York City.  We are deeply grateful to our generous sponsors for making this program possible.

Corporate Sponsors:  Incyte (Presenting Sponsor); PharmaEssentia; the SASS Foundation for Medical Research, Inc.; and Sierra Oncology.

Individual Sponsors: Laine and David Boule

The program featured presentations by distinguished basic scientists and clinical research physicians from the world’s leading MPN centers, which you can view below.

Play Video

Summary of MPN Research Presented at the 2018 American Society of Hematology Annual Meeting and 2019 Updates

Dr. Andrew I. Schafer (Weill Cornell Medicine, New York, NY) summarizes MPN research presented at the 2018 Annual Meeting of the American Society of Hematology and provides 2019 updates at the 10th International Symposium on Myeloproliferative Neoplasms, New York City, October 23, 2019.

Play Video

Immunotherapy

Dr. Hans Hasselbalch (Roskilde Hospital, University of Copenhagen, Denmark) discusses the latest developments in immunotherapy for myeloproliferative neoplasms (MPNs) at the 10th International Patient Symposium on Myeloproliferative Neoplasms (MPNs) in New York City, October 23, 2019.

Play Video

Why Patients with Polycythemia Vera and Myelofibrosis Should Be Treated with Interferon Early Rather than Late

Dr. Richard T. Silver (Weill Cornell Medicine, New York City) discusses why patients with polycythemia vera and myelofibrosis should be treated with interferon early rather than late at the 10th International Patient Symposium on Myeloproliferative Neoplasms (MPNs), October 23, 2019.

Play Video

Current Management of Myelofibrosis

Dr. Ronald Hoffman (Icahn School of Medicine at Mount Sinai, New York, NY) discusses the current management of myelofibrosis at the 10th International Patient Symposium on Myeloproliferative Neoplasms (MPNs) in New York City on October 23, 2019.

Play Video

Essential Thrombocythemia: A Case Study

Dr. Jerry L. Spivak (Johns Hopkins University School of Medicine, Baltimore) discusses essential thrombocythemia at the 10th International Patient Symposium on Myeloproliferative Neoplasms on October 23, 2019 in New York City.

Play Video

Current State of Stem Cell Transplants in MPN Therapy

Dr. Koen van Besien (Weill Cornell Medicine, New York, NY) discusses the current state of stem cell transplants in MPN therapy at the 10th International Patient Symposium on Myeloproliferative Neoplasms on October 23, 2019 in New York City.

Play Video

New MPN Treatments and Drugs

Dr. Srdan Verstovsek (University of Texas MD Anderson Cancer Center, Houston) discusses new MPN treatments and drugs at the 10th International Patient Symposium on Myeloproliferative Neoplasms on October 23, 2019 in New York City.

Play Video

Diet, Exercise, and Mindfulness

Dr. Robyn Scherber (UT Health San Antonio MD Anderson Cancer Center) discusses diet, exercise, and mindfulness for people living with myeloproliferative neoplasms (MPNs).

9th International Patient Symposium on Myeloproliferative Neoplasms

CR&T was proud to host the 9th International Patient Symposium on Myeloproliferative Neoplasms on Tuesday, November 1, 2017, at Weill Cornell Medical College in New York City.  We are deeply grateful to our generous sponsors for making this program possible.

Corporate Sponsors:  Incyte (Presenting Sponsor); PharmaEssentia; and the SASS Foundation for Medical Research, Inc.

Individual Sponsors: 

Platinum Sponsors: Mr. and Mrs. Myron J. Schuster; Silver Sponsors: Mr. and Mrs. Philip and Laureen Hidalgo; Bronze Sponsors: Laine and David Boule, Hande Taylin Or, Debra and Christopher Seiter; Donors: John Katz and Annete Albro Katz, Mr. and Mrs. Melvyn Oppenheim, Anonymous.

The program featured presentations by distinguished basic scientists and clinical research physicians from the world’s leading MPN centers, which you can view below.

Play Video

NATURAL HISTORY AND HEREDITY

Dr. Jerry L. Spivak (Johns Hopkins University School of Medicine, Baltimore) discusses natural history and heredity at the 9th International Symposium on Myeloproliferative Neoplasms, New York City, November 1, 2017. Dr. Spivak is introduced by Dr. Richard T. Silver, Vice President and Medical Director, CR&T.

Play Video

BIOMARKERS AND MOLECULAR ABNORMALITIES: WHAT DO PATIENTS NEED TO KNOW?

Dr. Alison Moliterno (Johns Hopkins University School of Medicine, Baltimore) discusses biomarkers and molecular abnormalities at the 9th International Symposium on Myeloproliferative Neoplasms, New York City, November 1, 2017.

Play Video

CURRENT MANAGEMENT OF POLYCYTHEMIA VERA

Dr. Richard T. Silver (Weill Cornell Medicine, New York City) discusses current management of polycythemia vera (PV) at the 9th International Symposium on Myeloproliferative Neoplasms, New York City, November 1, 2017

Play Video

CURRENT MANAGEMENT OF ESSENTIAL THROMBOCYTHEMIA

Dr. Carlos Besses (Hospital del Mar, Barcelona, Spain) discusses current management of essential thrombocythemia (ET) at the 9th International Symposium on Myeloproliferative Neoplasms, New York City, November 1, 2017.

Play Video

CURRENT MANAGEMENT OF MYELOFIBROSIS

Dr. Ronald Hoffman (Icahn School of Medicine at Mount Sinai, New York City) discusses current management of myelofibrosis at the 9th International Symposium on Myeloproliferative Neoplasms, New York City, November 1, 2017.

Play Video

CURRENT DEVELOPMENTS IN STEM CELL TRANSPLANTATION IN THE MPNS

Dr. Koen van Besien (Weill Cornell Medicine, New York City) discusses the latest developments in stem cell transplantation at the 9th International Symposium on Myeloproliferative Neoplasms, New York City, November 1, 2017

Play Video

SUMMARY OF DRUGS IN CURRENT AND FUTURE CLINICAL TRIALS

Dr. Jason Gotlib (Stanford University School of Medicine, Stanford, CA) discusses new drugs in current and future clinical trials at the 9th International Symposium on Myeloproliferative Neoplasms, New York City, November 1, 2017.

Play Video

WHAT SHOULD YOU EXPECT FROM YOUR MPN TREATMENT?

Dr. Ruben A. Mesa (UT Health San Antonio Cancer Center, TX) discusses what to expect from your MPN treatment at the 9th International Symposium on Myeloproliferative Neoplasms, New York City, November 1, 2017.

Watch Interviews with MPN Experts

Andrew Schorr of PatientPower.info, the online cancer community, conducted Facebook Live interviews with MPN experts at the Symposium, which you can view below. (Please note that you must have a Facebook account to access the videos.)

8th International Patient Symposium on Myeloproliferative Neoplasms

CR&T was proud to host the 8th International Patient Symposium on Myeloproliferative Neoplasms on Tuesday, November 4, 2015.  This full-day educational event, which takes place every two years, was held at the Belfer Research Building at Weill Cornell Medical College in New York City. The Symposium enables patients and their families to learn about the latest developments in MPN research and treatment. We are deeply grateful to our generous sponsors for making this event possible.

Corporate Sponsors: Incyte Corporation (Presenting Sponsor); Gilead; The SASS Foundation for Medical Research, Inc.; and Seattle Genetics.

Individual Sponsors:
Platinum Sponsors: Mr. and Mrs. Myron J. Schuster; Gold Sponsors: Paul and Susan Saltzman; Silver Sponsors: Mr. and Mrs. Keith Civil, Christopher and Debra Seiter; Bronze Sponsors: Laine and David Boule, Matthew and Nancy Crean, Terry Hermanson, Emily and Alan Legum, Bashi and Sam Nierenberg, Hande Taylin Or.

The program featured presentations by distinguished basic scientists and clinical research physicians from the world’s leading MPN centers, which you can view below.

Play Video

GENETICS OF MPNS: FROM INITIATION TO PROGRESSION

Presented by Robert Kralovics, PhD, Research Center for Molecular Medicine of The Austrian Academy of Science, Vienna, Austria

Play Video

LABORATORY APPROACHES TO STUDYING MPNS

Presented by Anne M. Mullally, MD, Dana-Farber/Brigham & Women’s Cancer Center, Boston, MA

Play Video

CURRENT DEVELOPMENTS IN POLYCYTHEMIA VERA TREATMENT: IS IT CURABLE?

Presented by Richard T. Silver, MD, Weill Cornell Medical College, New York, NY

Play Video

CURRENT DEVELOPMENTS IN MYELOFIBROSIS TREATMENT

Presented by Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX

Play Video

ESSENTIAL THROMBOCYTHEMIA: PATHOGENESIS AND MANAGEMENT

Presented by Jerry L. Spivak, MD, Johns Hopkins University School of Medicine, Baltimore, MD

Play Video

WHAT IS THE CLINICAL TRIAL PROCESS?

Presented by Jason Gotlib, MD, MS, Stanford University School of Medicine, Stanford, CA

Play Video

COMMON COMPLICATIONS OF THE MPNS

Presented by Andrew I. Schafer, MD, Weill Cornell Medical College, New York, NY

Play Video

WHAT CAN I EXPECT FROM MY MPN TREATMENT?

Presented by Ruben A. Mesa, MD, FACP, Mayo Clinic Cancer Center, Scottsdale, AZ